Effect of Rituximab On the Activity of T Cells Expressing CD20-Specific Chimeric Antigen Receptors

被引：0
|
作者：
Rufener, Gregory A. [1 ]
Jensen, Michael C. [2 ]
Brouns, Shaunda [3 ]
Budde, Lihua E. [4 ]
Maloney, David G. [4 ]
Press, Oliver W. [3 ]
Till, Brian G. [3 ]
机构：
[1] Creighton Univ, Omaha, NE 68178 USA
[2] Seattle Childrens Res Inst, Ben Towne Ctr Childhood Canc Res, Seattle, WA USA
[3] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA
[4] Univ Washington, Dept Med, Seattle, WA USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.4222.4222
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4222
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Preserved Activity of CD20-Specific Chimeric Antigen Receptor-Expressing T Cells in the Presence of Rituximab
    Rufener, Gregory A.
    Press, Oliver W.
    Olsen, Philip
    Lee, Sang Yun
    Jensen, Michael C.
    Gopal, Ajay K.
    Pender, Barbara
    Budde, Lihua E.
    Rossow, Jeffrey K.
    Green, Damian J.
    Maloney, David G.
    Riddell, Stanley R.
    Till, Brian G.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (06) : 509 - 519
  • [2] Preservation of CD20-Specific Chimeric Antigen Receptor T Cell Function in the Presence of Residual Rituximab
    Rufener, Gregory A.
    Olsen, Philip
    Lee, Sang Yun
    Jensen, Michael C.
    Gopal, Ajay K.
    Pender, Barbara
    Green, Damian J.
    Maloney, David C.
    Riddell, Stanley R.
    Press, Oliver W.
    Till, Brian G.
    BLOOD, 2015, 126 (23)
  • [3] CD20-Specific Chimeric Antigen Receptor- Expressing T Cells As Salvage Therapy in Rituximab-Refractory CD20(+) B-Cell Non-Hodgkin Lymphoma
    Li, Xin
    Cheng, Qian
    Liu, Rui
    Kang, Liqing
    Xu, Nan
    Li, Minghao
    Yu, Lei
    BLOOD, 2021, 138
  • [4] CD20-specific chimeric antigen receptor-expressing T cells as salvage therapy in rituximab-refractory/relapsed B-cell non-Hodgkin lymphoma
    Cheng, Qian
    Tan, Jingwen
    Liu, Rui
    Kang, Liqing
    Zhang, Yi
    Wang, Erhua
    Li, Ying
    Zhang, Jian
    Xiao, Han
    Xu, Nan
    Li, Minghao
    Yu, Lei
    Li, Xin
    CYTOTHERAPY, 2022, 24 (10) : 1026 - 1034
  • [5] Imaging of T cells expressing chimeric antigen receptors
    Roszik, Janos
    Rabinovich, Brian
    Cooper, Laurence J. N.
    IMMUNOTHERAPY, 2011, 3 (12) : 1411 - 1414
  • [6] T Cells Expressing CD19/CD20 Bispecific Chimeric Antigen Receptors Prevent Antigen Escape by Malignant B Cells
    Zah, Eugenia
    Lin, Meng-Yin
    Silva-Benedict, Anne
    Jensen, Michael C.
    Chen, Yvonne Y.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (06) : 498 - 508
  • [7] Preclinical Optimization of a CD20-specific Chimeric Antigen Receptor Vector and Culture Conditions
    Lee, Sang Yun
    Olsen, Philip
    Lee, Dong Hoon
    Kenoyer, Aimee L.
    Budde, Lihua E.
    O'Steen, Shyril
    Green, Damian J.
    Heimfeld, Shelly
    Jensen, Michael C.
    Riddell, Stanley R.
    Press, Oliver W.
    Till, Brian G.
    JOURNAL OF IMMUNOTHERAPY, 2018, 41 (01) : 19 - 31
  • [8] Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells
    Tina Müller
    Christoph Uherek
    Guitta Maki
    Kai Uwe Chow
    Annemarie Schimpf
    Hans-Georg Klingemann
    Torsten Tonn
    Winfried S. Wels
    Cancer Immunology, Immunotherapy, 2008, 57 : 411 - 423
  • [9] Functional bifurcation in T cells expressing chimeric antigen receptors
    Chang, ZeNan L.
    Silver, Pamela A.
    Chen, Yvonne Y.
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [10] T cells expressing CD26-specific chimeric antigen receptors exhibit extensive self-antigen-driven fratricide
    Zhou, Shu
    Zhu, Xiaoying
    Shen, Na
    Li, Qing
    Wang, Na
    You, Yong
    Zhong, Zhaodong
    Cheng, Fanjun
    Zou, Ping
    Zhu, Xiaojian
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2019, 41 (04) : 490 - 496
12345